Skip to content

Search the reference

Scientific profiles are awaiting evidence review.

Per- and polyfluoroalkyl substances (PFAS) in powdered infant formula: potential exposures and health risks

Quoted values stay tied to the cited study. Empty sections are gaps.

Summary

Primary formula testing is separated from the paper’s toxicokinetic modeling. Only reported occurrence and source-calculated formula concentrations enter held rows.

Key numbers

Source-reported values checked against the cited page of the filed PDF. Values are reported as printed, without conversion. These are selected records, not an exhaustive transcription.

analytevalueunitbasissource locationlimits and qualifiers
PFOS12 (0.6)ng/LLaboratory 20% w/v infant formula solution; mean (SD)PDF p.7 Table 3; preparation pp.3 to 4Measured solution, n = 3; PFOS LOQ 10 ng/L (p.5 Table 1).
PFOS0.054 (0.003)ng/gInfant formula powder; source-calculated dry-weight mean (SD)PDF p.7 Table 3; calculation p.4Derived by source from measured stock solution; not a separate direct powder measurement.
PFOS8.9ng/LFormula reconstituted according to label; source-calculated concentrationPDF p.7 Table 3; calculation p.4Derived by source; no new conversion made. Not the laboratory solution concentration.

6 further transcribed values remain under review and are not shown.

Evidence Fitness

Original formula measurements plus source-derived concentrations; all HOLD; MANIFEST tier SUPPORTIVE

Methods (brief)

Protein precipitation with acetonitrile, centrifugation and concentration; LC-MS/MS ESI MRM with isotope dilution and matrix-matched calibration (PDF pp.3 to 4).

Targets as printed or genericized: PFHxA; PFHpA; PFOA; PFNA; PFDA; PFUnA; PFBS; PFHxS; PFOS; PFOSA (PDF p.5 Table 1). PFBA; PFPeA; PFDoA were excluded after method-development problems (PDF p.4).

Limitations

MANIFEST SUPPORTIVE tier is retained as provenance, while the paper clearly includes original measurements. Measured solution, calculated powder and calculated feeding concentration are distinct records of the same detection, not independent samples. No serum-model or risk-limit finding is routed. No conversions, risk thresholds, representativeness claims, or safety conclusions are added.

Provenance notes

Local staged PDF copied unchanged. DOI checked in deposited PDF against MANIFEST; no external resolution attempted. Title and citation metadata checked against the PDF first page.

See the cell MISMATCHES.csv for unresolved discrepancies. The legacy MANIFEST analyte field is discovery metadata, not an audited target list.

Wiki pages updated on ingest

Infant Formula

PFBS

PFDA

PFHxA

PFHxS

PFNA

PFOA

PFOS